Medical cannabis could help patients suffering from certain medical conditions, and alleviate their suffering.
Cannabinoids, cannabis plant main bioactive ingredients, are increasingly acknowledged to possess medical benefits, and the markets are opening to export, forecasting the global market to reach $33 billion by 2024.
Cannabinoids are water insoluble, possess low oral bioavailability, extensively metabolized by the liver, chemically unstable, and have bitter unpleasant taste.
Biota aim is to develop innovative sublingual and buccal medical cannabis filmstrips that would provide oral trans-mucosal diffusion and direct absorption of cannabinoids into the blood-stream.
Based on Biota’s proprietary know-how gained during development of pharmaceutical and nutraceutical filmstrips, Biota’s medical cannabis filmstrips are designed to mask Cannabinoids unpleasant taste, and increase their solubility. Cannabinoids trans-mucosal absorption will bypass liver metabolism, and provide high bioavailability and fast onset of activity.
Secretive administration at any time and any location (private & public)
Convenient to carry and use, and provide standardized exact dosage
Range of flavors & colors w/ taste & odor masking
Pediatric & geriatric compliance
High loading capacity of CBD crystals / Cannabis oils
Scalable and versatile technology